Biogen Pharmachem Industries quarterly results and financials

Biogen Pharmachem Industries (BSE 531752)₹0.28000.00%(9 Nov 2026 close)Other Financial Services

Key facts

In the Jun 2026 quarter (standalone), Biogen Pharmachem Industries reported sales of ₹0.43 Cr and net profit of ₹0.21 Cr, down 84.2% year on year. For the year to Mar 2026, sales were ₹2.55 Cr and net profit ₹0.85 Cr.

Sales (Jun 2026): ₹0.43 Cr
Net profit (Jun 2026): ₹0.21 Cr
Sales (FY Mar 2026): ₹2.55 Cr
Net profit (FY Mar 2026): ₹0.85 Cr
EPS (Jun 2026): ₹0.00
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Biogen Pharmachem Industries quarterly results

₹ crore unless stated; each column is a quarter.

Biogen Pharmachem Industries Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.00	0.00	0.77	−0.08	0.00	0.00	1.34	0.00	0.00	0.53	0.57	0.43
Expenses	0.03	0.02	0.05	0.08	0.34	0.53	0.18	0.19	0.38	0.07	0.93	0.21
Operating Profit	−0.05	−0.04	0.75	−0.17	−0.36	−0.55	1.19	−0.21	−0.40	0.47	−0.37	0.23
OPM %	—	—	94.9%	—	—	—	87.4%	—	—	85.2%	−62.1%	50.1%
Other Income	0.77	0.08	0.00	0.00	−0.64	0.22	0.00	1.55	−0.11	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.73	0.07	0.73	−0.17	−1.01	−0.30	1.19	1.35	−0.48	0.47	−0.37	0.23
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	0.71	0.05	0.73	−0.15	−0.99	−0.30	1.17	1.33	−0.48	0.45	−0.35	0.21
EPS (Rs)	0.02	0.00	0.02	0.00	−0.02	0.00	0.03	0.02	0.00	0.00	0.00	0.00

Biogen Pharmachem Industries profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Biogen Pharmachem Industries Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.00	0.00	0.10	0.94	0.00	1.61	2.46	0.00	2.37	1.19	2.55	1.53
Expenses	0.04	0.13	6.73	0.96	0.11	3.23	2.48	0.44	0.46	1.50	1.59	1.59
Operating Profit	−0.04	−0.13	−6.64	0.00	−0.13	−1.61	−0.03	−0.46	1.94	−0.30	0.97	−0.07
OPM %	—	—	−6,009.1%	0.0%	—	−98.7%	−0.8%	—	81.1%	−24.2%	37.5%	−4.6%
Other Income	0.00	0.00	0.04	0.00	0.00	0.00	0.02	0.90	0.00	0.00	0.00	−0.11
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	−0.02	−0.13	−6.55	0.00	−0.11	−1.59	0.00	0.47	1.92	−0.30	0.97	−0.15
Tax %	0.0%	0.0%	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	10.3%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.01	0.00	0.00	0.00	—
Net Profit	−0.02	−0.11	−6.53	0.00	−0.11	−1.59	0.00	0.45	1.92	−0.28	0.85	−0.17
EPS (Rs)	0.00	0.00	−0.10	0.00	0.00	−0.03	0.00	0.02	0.04	0.00	0.02	0.00
Dividend payout %	0.0%	0.0%	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Biogen Pharmachem Industries balance sheet

₹ crore, at each year end.

Biogen Pharmachem Industries Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	65.40	65.35	65.34	65.31	65.35	65.33	65.30	65.30	65.30	65.25	65.41	90.44
Reserves	−4.26	−4.29	−4.41	−10.97	−10.98	−9.51	−11.12	−11.13	−10.66	−8.73	26.62	8.82
Borrowings	9.98	6.20	0.71	0.00	0.62	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	2.50	1.63	1.68	1.64	2.72	0.03	0.11	0.81	0.24	0.30	0.10	0.32
Total Liabilities	73.62	68.89	63.32	55.98	57.71	56.15	54.29	54.98	54.88	56.82	92.13	99.58
Fixed Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	43.91	26.76	22.45	3.53	6.27	6.47	9.52	6.97	8.87	5.45	23.89	32.88
Other Assets	29.71	42.13	40.87	52.45	51.44	49.68	44.77	48.01	46.01	51.37	68.24	66.70
Trade receivables	1.01	0.00	0.00	7.01	8.01	8.01	2.99	0.00	0.00	0.00	0.00	0.00
Cash & equivalents	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.99	0.00
Total Assets	73.62	68.89	63.32	55.98	57.71	56.15	54.29	54.98	54.88	56.82	92.13	99.58

Biogen Pharmachem Industries cash flow

₹ crore, for each year.

Biogen Pharmachem Industries Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−7.29	4.69	−0.08	−13.67	0.10	−1.22	3.96	1.41	1.71	1.95	−1.09	1.58
Cash from investing activity	17.07	17.07	4.29	14.33	−0.71	1.53	−3.65	−1.31	−1.65	−2.05	−32.63	−9.55
Cash from financing activity	−11.20	−21.73	−4.32	−0.70	0.61	−0.31	−0.30	0.00	0.00	0.00	35.69	6.29
Net cash flow	−1.39	0.03	−0.08	−0.02	−0.01	0.00	0.00	0.07	0.04	−0.10	1.99	−1.68
Free cash flow	−7.29	4.69	−0.06	−13.64	0.10	−1.22	3.96	1.39	1.71	1.95	−1.09	1.58
CFO / OP %	18,200.0%	−15,600.0%	58.0%	207.0%	—	1,008.0%	−247.0%	−7,000.0%	−378.0%	101.0%	372.0%	164.0%

Biogen Pharmachem Industries ratios

Working-capital days and returns, by year.

Biogen Pharmachem Industries Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	—	—	—	23,326	3,084	—	571	0	—	0	0	0
Inventory days	—	—	—	—	0	—	0	0	—	—	—	—
Cash conversion cycle	—	—	—	23,327	3,085	—	572	0	—	0	0	0
Working capital days	—	—	—	23,195	2,652	—	551	153	—	−34	171	−19
ROCE %	−0.2%	−0.0%	−0.2%	−11.3%	0.0%	−0.2%	−2.9%	−0.0%	−0.4%	3.5%	−0.4%	1.0%

Biogen Pharmachem Industries: frequently asked questions

What are the latest quarterly results of Biogen Pharmachem Industries?

For the Jun 2026 quarter, Biogen Pharmachem Industries reported sales of ₹0.43 Cr and net profit of ₹0.21 Cr, down 84.2% year on year. The operating margin was 50.1%.

What is the annual revenue of Biogen Pharmachem Industries?

Biogen Pharmachem Industries' sales for the year to Mar 2026 were ₹2.55 Cr; over the last twelve months they were ₹1.53 Cr.

What is the net profit of Biogen Pharmachem Industries?

Net profit for the year to Mar 2026 was ₹0.85 Cr, and −₹0.17 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.00.

How much debt does Biogen Pharmachem Industries have?

Biogen Pharmachem Industries reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.

What is the free cash flow of Biogen Pharmachem Industries?

Cash from operations was ₹1.58 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1.58 Cr.

Loading…